Latest News about SMMT
Recent news which mentions SMMT
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
October 24, 2024
From Motley Fool
Billionaire Bob Duggan Snags $33M Miami Penthouse Amid Summit Therapeutics 689% Stock Rally
October 24, 2024
From Benzinga
Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You?
October 22, 2024
Tickers
SMMT
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 16, 2024
From Benzinga
Up 700% This Year, Is It Too Late to Invest in This Stock?
October 15, 2024
From Motley Fool
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
October 13, 2024
From Motley Fool
3 Things You Need to Know If You Buy Summit Therapeutics Stock Today
October 12, 2024
Tickers
SMMT
From Motley Fool
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
October 07, 2024
From Motley Fool
Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
October 06, 2024
From Benzinga
Could Summit Therapeutics Become the Next Merck?
October 04, 2024
From Motley Fool
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
October 04, 2024
From Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
October 02, 2024
From Benzinga
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
September 29, 2024
From Benzinga
2 High-Potential Growth Stocks You Shouldn't Overlook
September 29, 2024
From Motley Fool
Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
September 28, 2024
From Motley Fool
2 Stocks Up Over 700% in 2024 That Could Soar Even Further
September 25, 2024
From Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
From Benzinga
Tickers
SMMT
From Motley Fool
Is It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year?
September 19, 2024
Tickers
SMMT
From Motley Fool
This Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous.
September 18, 2024
From Motley Fool
Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study
September 17, 2024
From Benzinga
Here's Why Everyone's Talking About Summit Therapeutics
September 17, 2024
From Motley Fool
Alphabet To $200? Here Are 10 Top Analyst Forecasts For Monday
September 16, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.